ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Krebs Biochemicals and Industries Limited has issued a notice for its 34th Annual General Meeting scheduled for September 29, 2026. Key agenda items include the approval of financial statements and related party transactions.
Krebs Biochemicals & Industries Limited has submitted its 34th Annual Report for the financial year 2025-26. The report includes financial highlights, directors' report, and audited financial statements.
Krebs Biochemicals & Industries Ltd reported revenue from operations of ₹7 Cr (+27.3% YoY) and a net loss of ₹2.5 Cr for Q1 FY27.
Krebs Biochemicals & Industries has scheduled a board meeting for August 6, 2026. The board will consider and adopt the unaudited Q1 results for June 30, 2026.
Krebs Biochemicals and Industries Ltd filed its shareholding pattern for June 2026, detailing promoter, institutional and other holdings. 20,400 promoter shares are in court dispute and remain undematerialised.